Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    0.00 (0.00%)
Bid:
1,015.00
Ask:
1,203.00
Spread: 188.00 (18.522%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

22 Apr 2010 07:00

RNS Number : 5867K
Persimmon PLC
22 April 2010
 



INTERIM MANAGEMENT STATEMENT

THURSDAY 22 APRIL 2010

 

 

 

Persimmon plc is holding its Annual General Meeting at 12 noon today at York Racecourse where the following comments will be made regarding current trading, financial performance and the outlook for the financial year. This statement, which supplements the update given at the time of our 2009 results, covers the period from 1 January 2010 to the date of this announcement and constitutes Persimmon Plc's first Interim Management Statement in 2010.

 

Since we announced our results for the year ended 31 December 2009 on 2 March 2010 weekly sales volumes have remained consistent despite a backdrop of continued uncertainty regarding the wider economic outlook and the forthcoming General Election. Total sales, including legal completions to date, are c. 20% ahead of last year at c. £1.15 billion. Sales volumes are c. 11% ahead including a higher content of private sales and prices remain firm. Encouragingly, weekly visitors per site are constant with good conversion to reservations. Cancellation rates remain at historically low levels.

 

Maintaining an appropriate level of sales while focusing on achieving price growth in all regions continues to form the basis of our current strategy. Margin improvement remains a priority.

 

We are opening new developments in line with our planned investment programme while closely monitoring working capital levels across the business. We are currently operating from c. 375 sites having opened 50 new sites through the first quarter of the year in line with our expectations. We have a further 40 sites which we currently intend to start during the second quarter. These new site openings will provide us with the opportunity to secure some further price improvement and maintain sales momentum.

 

We continue to focus on minimising build costs and on the strict control of overhead costs.

 

Against this background of trading we are carefully selecting land opportunities for investment. Whilst we continue to apply strict criteria to land purchases, we have recently acquired some excellent sites including some from our strategic land portfolio upon which we have now received residential planning consents. This new land will generate higher margins as development commences during the next 12 months.

 

At the end of March, the point in the financial year where we approach our traditional peak seasonal working capital requirements, net borrowings were at c. £265 million (31 March 2009: £680 million). Debt levels are expected to reduce further as the year progresses.

 

With margin improvement underway, cash generation remaining robust, and our high quality consented and strategic landbanks, we are in a strong position in the UK housing market to deliver profitable growth.

 

We will give a further update on trading on Tuesday 6 July 2010 following the half year end.

 

For further information, please contact:

 

 

M:Communications

Edward Orlebar

Tel: +44 (0) 7738 724 630

Charlotte McMullen

Tel: +44 (0) 207 920 2349

Marylène Guernier

Tel: +44 (0) 7776 303 788

 

Persimmon plc

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Tel: +44 (0) 1904 642199

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAVNRROASUAR
Date   Source Headline
2nd Jul 201810:36 amRNSTotal Voting Rights
28th Jun 201810:53 amRNSDirectorate Change
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
1st Jun 20184:10 pmRNSTotal Voting Rights
1st Jun 20181:43 pmRNSBlock listing Interim Review
1st May 20183:08 pmRNSTotal Voting Rights
25th Apr 20184:21 pmRNSResult of AGM
25th Apr 20187:00 amRNSTrading Update
17th Apr 20188:30 amRNSCapital Markets Event
13th Apr 201810:45 amRNSDirector/PDMR Shareholding
9th Apr 20189:49 amRNSExtension of Bank Facilities
3rd Apr 20184:30 pmRNSTotal Voting Rights
3rd Apr 20184:30 pmRNSDirector/PDMR Shareholding
29th Mar 20181:32 pmRNSDirector/PDMR Shareholding
19th Mar 201811:59 amRNSAnnual Financial Report
15th Mar 20184:35 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAppointment of Chairman
8th Mar 20183:53 pmRNSDirector/PDMR Shareholding
2nd Mar 20184:05 pmRNSDirector/PDMR Shareholding
1st Mar 20186:10 pmRNSTotal Voting Rights
28th Feb 20185:31 pmRNSEBT Share Purchase
27th Feb 20187:00 amRNSBoard Changes
27th Feb 20187:00 amRNSFinal Results
23rd Feb 20187:00 amRNSReduction of 2012 LTIP Awards
1st Feb 201812:20 pmRNSTotal Voting Rights
9th Jan 20187:00 amRNSTrading Update
2nd Jan 201811:17 amRNSTotal Voting Rights
21st Dec 20175:08 pmRNSDirector/PDMR Shareholding
20th Dec 20175:31 pmRNSDirector/PDMR Shareholding
15th Dec 20177:00 amRNSBoard Changes
11th Dec 20175:06 pmRNSDirector/PDMR Shareholding
1st Dec 20175:01 pmRNSDirector/PDMR Shareholding
1st Dec 20174:58 pmRNSBlock listing Interim Review
1st Dec 20174:55 pmRNSTotal Voting Rights
20th Nov 20179:55 amRNSHolding(s) in Company
8th Nov 20177:00 amRNSTrading Statement
6th Nov 20179:38 amRNSAdditional Listing
1st Nov 20174:51 pmRNSTotal Voting Rights
31st Oct 20172:39 pmRNSHolding(s) in Company
23rd Oct 20173:43 pmRNSDirector/PDMR Shareholding
16th Oct 20174:32 pmRNSHolding(s) in Company - Replacement
16th Oct 201711:45 amRNSHolding(s) in Company
11th Oct 20173:25 pmRNSHolding(s) in Company
5th Oct 20174:22 pmRNSHolding(s) in Company
2nd Oct 20175:01 pmRNSTotal Voting Rights
1st Sep 20174:18 pmRNSTotal Voting Rights
1st Sep 20179:00 amRNSAdditional Listing
22nd Aug 20177:00 amRNSHalf Year Results
5th Jul 20177:00 amRNSTrading Update
27th Jun 20175:40 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.